Company: LRHC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032211
Chunk: 3155

Company: La Rosa Holdings Corp.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 10
Chunk 3155
---
 which was established to help U.S. businesses invest overseas, fostering economic
development in new and emerging markets, complementing the private sector in managing the risk associated with foreign direct investment
and supporting U.S. foreign policy. Appointed by Governor Jeb Bush, Ambassador Siegel served as a Member of the Board of Directors of
Enterprise Florida, Inc. (“EFI”) from 1999-2004. EFI is the state of Florida’s primary organization promoting statewide
economic development through its public-private partnership. From February 2011 to April 2019, Ambassador Siegel served on the Board of
Directors of PositiveID Corporation (OTCQB: PSID). From April 2014 to March 2020, Ambassador Siegel served as a director of the Board
of Notis Global Inc. (OTC: NGBL). Ambassador Siegel presently serves on the Board of Directors of the following companies: Janover Inc.
(Nasdaq: JNVR)(from July 2023), Worksport Ltd, (Nasdaq: WKSP) (from August 2021), Vocodia Holdings Corp., (CBOE: VHAI) (from January 2023),
and Bannix Acquisition Corp. (Nasdaq: BNIX) (from November 2022). He also presently serves in an advisory capacity to the U.S. Medical
Glove Company. Ambassador Siegel received a B.A. from the University of Connecticut in 1973 and a J.D. from the Dickinson School of Law
in 1976. In December 2014, he received an honorary degree of Doctor of Business Administration from the University of South Carolina.
We believe that Ambassador Siegel’s vast professional experience, education, and professional credentials qualify him to serve as
a member of the Company’s Board, and as an independent member of the Board’s committees.

Lourdes
Felix was appointed to serve as a member of the Company’s Board effective April 2024. Ms. Felix is an entrepreneur
and corporate finance executive with 30 years of combined experience in capital markets, public accounting and in the private
sector. She currently serves as Chief Executive Officer, Chief Financial Officer, and a member of the board of directors of BioCorRx
Inc. (OTCQB: BICX), a company focused on addiction treatment solutions and related disorders. She has been with BioCorRx since
October 2012. Ms. Felix is one of the founders and President of Bio